Literature DB >> 7212976

Side effects of corticosteroid therapy. Psychiatric aspects.

M H Ling, P J Perry, M T Tsuang.   

Abstract

We reviewed the literature to determine the characteristics of corticosteroid-induced mental disturbances. We conclude that (1) while dosage may be correlated to the risk of developing mental disturbances, neither dosage nor duration of treatment seems to affect the time of onset, duration, severity, or type of mental disturbances; (2) euphoria, depression, and psychotic reactions are the common manifestations of corticosteroid-induced mental disturbances; (3) females seem to be more prone to these disturbances than males; (4) patients with past mental illness are not necessarily predisposed to such disturbances; and (5) corticosteroid-induced mental disturbances are usually reversible on dose reduction or discontinuation of the drug. At present there are no simple models to explain the psychotic reactions, anxiety, or agitation seen in corticosteroid-induced mental disturbances.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7212976     DOI: 10.1001/archpsyc.1981.01780290105011

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  46 in total

1.  Using the Children's Depression Inventory in youth with inflammatory bowel disease: support for a physical illness-related factor.

Authors:  Rachel D Thompson; Anna E Craig; Christine Mrakotsky; Athos Bousvaros; David R DeMaso; Eva Szigethy
Journal:  Compr Psychiatry       Date:  2012-06-06       Impact factor: 3.735

2.  The Douglas Hospital Longitudinal Study of Normal and Pathological Aging: summary of findings.

Authors:  Sonia J Lupien; Georges Schwartz; Ying Kin Ng; Alexandra Fiocco; Nathalie Wan; Jens C Pruessner; Michael J Meaney; N P Vasavan Nair
Journal:  J Psychiatry Neurosci       Date:  2005-09       Impact factor: 6.186

Review 3.  Psychological and behavioural effects of endogenous testosterone levels and anabolic-androgenic steroids among males. A review.

Authors:  M S Bahrke; C E Yesalis; J E Wright
Journal:  Sports Med       Date:  1990-11       Impact factor: 11.136

Review 4.  Glucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus?

Authors:  Mitchel A Kling; Victoria H Coleman; Jay Schulkin
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

Review 5.  Adverse neurologic effects of glucocorticosteroids.

Authors:  D Lacomis; M A Samuels
Journal:  J Gen Intern Med       Date:  1991 Jul-Aug       Impact factor: 5.128

Review 6.  Delirium in hospitalized elderly.

Authors:  J Francis; W N Kapoor
Journal:  J Gen Intern Med       Date:  1990 Jan-Feb       Impact factor: 5.128

7.  Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission.

Authors:  P V Piazza; M Barrot; F Rougé-Pont; M Marinelli; S Maccari; D N Abrous; H Simon; M Le Moal
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

Review 8.  Corticosteroids and Cognition: A Meta-Analysis.

Authors:  Catherine E Prado; Simon F Crowe
Journal:  Neuropsychol Rev       Date:  2019-05-26       Impact factor: 7.444

Review 9.  Stress and neurodevelopmental processes in the emergence of psychosis.

Authors:  C W Holtzman; H D Trotman; S M Goulding; A T Ryan; A N Macdonald; D I Shapiro; J L Brasfield; E F Walker
Journal:  Neuroscience       Date:  2013-01-05       Impact factor: 3.590

Review 10.  Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus.

Authors:  Samir D Bhangle; Neil Kramer; Elliot D Rosenstein
Journal:  Rheumatol Int       Date:  2013-04-16       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.